Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
- 2014 -
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
May 2014 - 45 products
L
IP
V/S
Fluarix Tetra 15 µg / 0.5 ml
9.58
26.85
10 %
GlaxoSmithKline AG
B / SL
FB
G
IP
V/S
Fluarix Tetra 15 µg / 0.5 ml
10
PR
PR
k.A.
GlaxoSmithKline AG
B
FB
G
L
IP
CI
Imatinib-Teva 100 mg
60 Tablet(s)
462.06
518.95
10 %
Coated tablets: Imatinibum 100 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
CI
Imatinib-Teva 400 mg
30 Tablet(s)
923.22
1020.45
10 %
Coated tablets: Imatinibum 400 mg
Teva Pharma AG
A / SL / SG
FB
G
IP
CI
Valganciclovir-Mepha 450
60 Tablet(s)
1054.01
1162.70
10 %
Coated tablets: Valganciclovirum 450 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Celecoxib Sandoz 100 mg
30 Capsule(s)
8.97
26.15
10 %
Capsules: Celecoxibum 100 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib Sandoz 200 mg
30 Capsule(s)
14.86
32.55
10 %
Capsules: Celecoxibum 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib Sandoz 200 mg
100 Capsule(s)
46.27
66.60
10 %
Capsules: Celecoxibum 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib Zentiva 100 mg
30
8.97
26.15
10 %
Capsules: Celecoxibum 100 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib Zentiva 200 mg
30
14.86
32.55
10 %
Capsules: Celecoxibum 200 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib Zentiva 200 mg
100
46.27
66.60
10 %
Capsules: Celecoxibum 200 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
PP
Betmiga 25 mg
30 Tablet(s)
36.74
56.35
10 %
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 25 mg
90 Tablet(s)
108.15
134.05
10 %
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 50 mg
30 Tablet(s)
36.74
56.35
10 %
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 50 mg
90 Tablet(s)
108.15
134.05
10 %
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B / SL
FB
G
L
IP
CI
PP
Dificlir
20 Tablet(s)
1582.19
1737.15
10 %
Coated tablets: Fidaxomicinum 200 mg
Tillotts Pharma AG
A / SL
FB
G
IP
CI
Rifampicin Labatec 450 mg
30 Tablet(s)
61.52
83.30
10 %
Coated tablets: Rifampicinum 450 mg
Labatec Pharma SA
A / SL
FB
G
IP
CI
Rifampicin Labatec 600 mg
30 Tablet(s)
82.03
105.65
10 %
Coated tablets: Rifampicinum 600 mg
Labatec Pharma SA
A / SL
FB
G
L
IP
CI
PP
Tivicay 50 mg
30 Tablet(s)
631.26
702.95
10 %
Coated tablets: Dolutegravirum 50 mg
ViiV Healthcare GmbH
A / SL
FB
G
IP
CI
PP
Dexilant 30 mg
14 Capsule(s)
12.26
29.75
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Dexilant 30 mg
28 Capsule(s)
21.58
39.90
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Dexilant 30 mg
98 Capsule(s)
67.80
90.15
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 30 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Dexilant 60 mg
14 Capsule(s)
14.41
32.10
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Dexilant 60 mg
28 Capsule(s)
25.36
44.00
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Dexilant 60 mg
56 Capsule(s)
47.26
67.80
10 %
Kapseln mit veränderter Wirkstofffreisetzung: Dexlansoprazolum 60 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 250 IE
Set(s)
163.35
208.65
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 250 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 500 IE
Set(s)
326.70
376.25
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 500 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 1000 IE
Set(s)
653.40
711.45
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 1000 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 2000 IE
Set(s)
1306.80
1381.80
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 2000 UI
Takeda Pharma AG
B / SL
FB
G
IP
Rifampicin Labatec i.v.
300mg
Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Rifampicinum 300 mg
Labatec Pharma SA
A
FB
G
IP
Rifampicin Labatec i.v.
300mg
10 Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Rifampicinum 300 mg
Labatec Pharma SA
A
FB
G
IP
Rifampicin Labatec i.v.
600mg
Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Rifampicinum 600 mg
Labatec Pharma SA
A
FB
G
IP
Rifampicin Labatec i.v.
600mg
10 Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Rifampicinum 600 mg
Labatec Pharma SA
A
FB
G
IP
CI
PP
Betmiga 25 mg
10 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B
FB
G
IP
CI
PP
Betmiga 50 mg
10 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B
FB
G
IP
CI
Rifampicin Labatec 450 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: Rifampicinum 450 mg
Labatec Pharma SA
A
FB
G
IP
CI
Rifampicin Labatec 600 mg
10 Tablet(s)
PR
PR
k.A.
Coated tablets: Rifampicinum 600 mg
Labatec Pharma SA
A
FB
G
IP
CI
Rifampicin Labatec 600 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: Rifampicinum 600 mg
Labatec Pharma SA
A
FB
G
IP
Rixubis 3000 IE
Set(s)
2008.66
2101.95
k.A.
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 3000 UI
Takeda Pharma AG
B
FB
G
IP
CI
Drospibel 20 Conti
28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
3 x 28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
6 x 28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
3 x 28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
6 x 28 Tablet(s)
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
